212 related articles for article (PubMed ID: 23951246)
1. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Zebrafish Follicle-Stimulating Hormone Receptor (fshr) But Not Luteinizing Hormone Receptor (lhcgr) Gene by TALEN Leads to Failed Follicle Activation in Females Followed by Sexual Reversal to Males.
Zhang Z; Lau SW; Zhang L; Ge W
Endocrinology; 2015 Oct; 156(10):3747-62. PubMed ID: 25993524
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of gonadotropin receptors (fshr and lhcgr) by estradiol in the zebrafish ovary involves nuclear estrogen receptors that are likely located on the plasma membrane.
Liu KC; Lin SW; Ge W
Endocrinology; 2011 Nov; 152(11):4418-30. PubMed ID: 21878512
[TBL] [Abstract][Full Text] [Related]
4. β-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line.
Casarini L; Reiter E; Simoni M
Mol Cell Endocrinol; 2016 Dec; 437():11-21. PubMed ID: 27502035
[TBL] [Abstract][Full Text] [Related]
5. The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.
Heublein S; Mayr D; Friese K; Jarrin-Franco MC; Lenhard M; Mayerhofer A; Jeschke U
Int J Mol Sci; 2014 Aug; 15(9):15161-72. PubMed ID: 25167139
[TBL] [Abstract][Full Text] [Related]
6. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
7. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
[TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
9. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
10. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
Lindgren I; Bååth M; Uvebrant K; Dejmek A; Kjaer L; Henic E; Bungum M; Bungum L; Cilio C; Leijonhufvud I; Skouby S; Andersen CY; Giwercman YL
Hum Reprod; 2016 Mar; 31(3):672-83. PubMed ID: 26769719
[TBL] [Abstract][Full Text] [Related]
11. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of LH and FSH receptors after hCG and eCG treatments in the porcine oviduct.
Małysz-Cymborska I; Andronowska A
Domest Anim Endocrinol; 2016 Oct; 57():48-54. PubMed ID: 27565230
[TBL] [Abstract][Full Text] [Related]
13. Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC).
Bose CK
J Exp Ther Oncol; 2007; 6(3):201-4. PubMed ID: 17552360
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
Long L; Cao Y; Tang LD
Int J Gynecol Cancer; 2012 May; 22(4):539-45. PubMed ID: 22495744
[TBL] [Abstract][Full Text] [Related]
15. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of gonadotropin receptors by bone morphogenetic proteins in the zebrafish ovary.
Li CW; Zhou R; Ge W
Gen Comp Endocrinol; 2012 May; 176(3):420-5. PubMed ID: 22240277
[TBL] [Abstract][Full Text] [Related]
17. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
18. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
20. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK
Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
